McDermott Advised Sellers of Arges Group on its Sale to Novanta - McDermott Will & Emery

McDermott Advised Sellers of Arges Group on its Sale to Novanta


McDermott Will & Emery advised the sellers of Arges Group on the sale of all shares in Germany based Arges GmbH including its subsidiary to Novanta Inc. The closing of the transaction is expected for the third quarter of 2019 and is subject to approval of the German Federal Cartel Office (Bundeskartellamt).

Arges located in Wackersdorf, Germany, develops and manufactures innovative laser scanning systems for positioning and deflecting laser beams in industrial materials processing and medical applications, in particular for the field of ophthalmology.

Boston-based Novanta Inc. is a corporation publicly listed on the NASDAQ Global Select Market. The company is a leading global supplier of core technology solutions for medical and advanced industrial equipment manufacturers.

The McDermott team advising Arges was led by Frankfurt corporate partner Clemens Just and included Joseph W. Marx, Richard Mitchell, Norman Wasse, Maximilian Clostermeyer, Isabelle Suzanne Müller, Heiko Kermer, Gudrun Germakowski, Julian Jäger, Steffen Woitz, Daniel von Brevern and Mirjam Büsch.

About McDermott

McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. With more than 20 locations on three continents, our team works seamlessly across practices, industries and geographies to deliver highly effective – and often unexpected – solutions that propel success. More than 1,100 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.

Media Contacts